Quarterly UpdatesApr 27, 2026, 05:22 PM
MANE Preliminary Cash, Equivalents $390.8M as of March 31, 2026
AI Summary
Veradermics, Inc. reported preliminary unaudited cash, cash equivalents, and marketable securities of approximately $390.8 million as of March 31, 2026. The company noted that this amount is subject to completion of financial closing procedures and may differ materially from the final figures. The company's auditor has not audited, reviewed, or expressed an opinion on this preliminary financial data.
Key Highlights
- Veradermics, Inc. reported preliminary unaudited cash, cash equivalents, and marketable securities of approximately $390.8 million.
- The reported cash balance is as of March 31, 2026.
- The amount is preliminary and unaudited, subject to completion of financial closing procedures.
- The final amount may differ materially from the preliminary figure.
- Deloitte & Touche LLP, the company's auditor, has not audited, reviewed, or expressed an opinion on this preliminary data.
Price Impact
More from MANE